摘要 |
Methods are provided for treating cancer in a patient in need thereof comprising: determining whether said patient has at least one polymorphism in VEGFA (rs3025039, VEGFA 936C>T), VEGFR (rs1870377, Q427H, VEGFR2 18487A>T, 1416A>T) or IGF1R (rs2037448, 229741A>G or rs7181022, 28322C>T); and if said patient has at least one polymorphism, administering to said patient a HER2 inhibitor. |